Back
Armata Pharmaceuticals Stock Predictions
![](/images/offers/ims/large/offer8.jpg)
Recent Tech Boom Could Send "EarnPhone" Soaring
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
ARMP
Armata Pharmaceuticals
Last Price:
$2.01
Seasonality Move:
0.79%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer4.jpg)
Elon Musk Dreams, Mode Mobile Delivers
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Armata Pharmaceuticals Stock Forecast
-
Is Armata Pharmaceuticals Stock Undervalued?The current Armata Pharmaceuticals [ARMP] share price is $1.95. The Score for ARMP is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
ARMP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Armata Pharmaceuticals Stock Go Up Next Year?
Data Unavailable
Armata Pharmaceuticals Stock Rating
Data Unavailable
Armata Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
armatapharma.com
52-Week Data
52-Week High:
4.48
52-Week Low:
1.80
Prediction Charts
Market Cap:
70.6M
Price in USD:
1.95
Volume:
3.8K
Beta:
1.69
Technical Analysis
SMA50:
2.07
SMA100:
2.20
SMA200:
2.42
52-Wk Change:
-44.76%
Stock Predictions
-
Is Armata Pharmaceuticals stock public?Yes, Armata Pharmaceuticals is a publicly traded company.
-
What is the Armata Pharmaceuticals stock quote today?The Armata Pharmaceuticals stock price is 1.95 USD today.
-
How to buy Armata Pharmaceuticals stock online?You can buy Armata Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jan-24 | 2.24 | 2.15 | 2.37 | 2.14 |
Jan-27 | 2.13 | 2.02 | 2.13 | 2.01 |
Jan-28 | 2.07 | 2.08 | 2.13 | 2.07 |
Jan-29 | 2.02 | 2.04 | 2.07 | 2.01 |
Jan-30 | 2.05 | 2.05 | 2.06 | 2.05 |
Jan-31 | 2.09 | 2.00 | 2.12 | 2.00 |
Feb-3 | 1.99 | 2.03 | 2.10 | 1.97 |
Feb-4 | 2.00 | 2.02 | 2.04 | 2.00 |
Feb-5 | 2.05 | 2.04 | 2.06 | 2.02 |
Feb-6 | 2.07 | 2.04 | 2.08 | 2.00 |
Feb-7 | 2.12 | 2.08 | 2.12 | 2.00 |
Feb-10 | 2.06 | 2.02 | 2.22 | 2.00 |
Feb-11 | 1.98 | 1.99 | 2.09 | 1.93 |
Feb-12 | 2.01 | 1.95 | 2.06 | 1.95 |
Armata Pharmaceuticals Earnings
Data Unavailable
Armata Pharmaceuticals Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.75 per share, and a decrease next year of $0.00 per share.
* Armata Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.